0012 GMT - Mondelez's CEO said the broader snacking category is not diminishing due to consumers' focus on health and wellness. There hasn't been any noticeable decrease in snacking consumption due to GLP-1 medications, either, Dirk Van de Put said. "Since COVID, the indulgence part of snacking is growing just as fast as the healthy part," he said. The snack giant reported a profit of $1.75 billion for the fourth quarter, compared with $950 million a year earlier. (roshan.fernandez@wsj.com)
(END) Dow Jones Newswires
February 04, 2025 19:13 ET (00:13 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。